CJC-1295 DAC 5mg – Lyophilized Peptide for Laboratory Research

Product Overview

CJC-1295 DAC 5mg is a lyophilized peptide product supplied in a sealed 7 mL vial. It is presented as a dry powder and has not been reconstituted. The product is intended for laboratory research applications where peptide identity, sample quality, and documented testing are important considerations.

CJC-1295 DAC is known in scientific literature as a modified peptide studied for its interaction with growth hormone-releasing hormone (GHRH) receptors and its effects on growth hormone regulation in experimental settings. The DAC component refers to Drug Affinity Complex technology, a modification designed to extend the duration of a peptide’s activity in biological research models.

At Global Peptides Lab, clear product specifications and batch-specific analytical information help researchers identify the material supplied and review the available quality-control results before making purchasing decisions.

This product is intended strictly for laboratory research and analytical applications. It is not approved for general human use, and this product description does not constitute medical advice or a recommendation for personal use.

Product Specifications

The following specifications describe the product supplied.

• Product name: CJC-1295 DAC Peptide
• Labelled product amount: 5 mg
• Physical form: Lyophilized powder
• Container type: Vial
• Vial size: 7 mL (6R)
• Reconstitution status: Not reconstituted
• Reported purity: 99.464%
• Reported measured weight: 6.08 mg
• Batch number: CJD06261105j
• Date tested: May 11, 2026

The labelled amount and reported measured weight are different specifications. The product is labelled as 5 mg, while the supplied batch information records a measured weight of 6.08 mg. Gross or total sample weight should not automatically be interpreted as the quantity of pure peptide. The exact basis of the weight measurement should be confirmed using the associated laboratory documentation.

Understanding CJC-1295 DAC

CJC-1295 DAC is a synthetic peptide investigated in relation to growth hormone-releasing hormone signalling. GHRH is involved in regulating growth hormone release from the pituitary gland. Researchers study peptide structures and modifications to better understand their biological activity, stability, and behaviour in experimental systems.

The DAC modification is an important distinguishing feature because it is designed to support longer-lasting interactions with circulating proteins, potentially extending a peptide’s activity compared with shorter-acting forms. Actual behaviour depends on the compound, experimental conditions, and study design.

CJC-1295 DAC should not be confused with every product sold under the broader CJC-1295 name. Product naming, peptide modifications, and the presence or absence of DAC can affect how a material is described in research literature.

For laboratory identification, researchers should review the exact product designation and the available analytical documentation rather than relying on a product name alone.

Laboratory Testing and Quality Information

Quality-control testing can provide useful information about a research material’s measured characteristics. The supplied batch record for this product includes results for purity, weight, TFA, sterility, and endotoxins (LPS).

Reported Purity: 99.464%

The supplied test information reports a purity result of 99.464%. Purity is an analytical measure that helps characterise a sample’s composition under a specified testing method.

The meaning of a purity percentage depends on the analytical technique, sample preparation, and calculation method. For this reason, the corresponding test report should be consulted to understand the method used and what the reported result represents.

Reported Weight: 6.08 mg

The batch information records a measured weight of 6.08 mg. This measurement is presented separately from the product’s labelled amount of 5 mg.

Researchers should review the original documentation for the measurement method and the basis of the reported weight. The recorded weight alone does not establish the amount of active peptide in the sample.

TFA Test: Pass

TFA refers to trifluoroacetic acid, which can be relevant to peptide synthesis and purification. The supplied batch information records a passing TFA test.

A passing result should be interpreted according to the laboratory’s test method and acceptance criteria. It should not be taken to mean that every possible impurity has been excluded.

Sterility Test: Pass

The supplied record reports a passing sterility test. Sterility testing evaluates samples for evidence of microbial contamination under specified conditions.

A passing result relates to the scope and limitations of the test performed. It is not, by itself, a guarantee of sterility throughout storage, handling, transport, or subsequent laboratory use.

Endotoxins (LPS): Pass

Lipopolysaccharides (LPS), commonly called endotoxins, are components associated with the outer membrane of certain bacteria. Endotoxin testing is an important part of quality assessment for materials where contamination may affect experimental results.

The supplied batch record lists the endotoxin test as passing. The numerical result, detection limit, test method, and acceptance threshold should be checked in the supporting documentation if those details are required for a particular research application.

Batch-Specific Test Results

The following table summarises the information supplied for this batch.

Test or specification	Reported result
Batch number	CJD06261105j
Test date	May 11, 2026
Purity	99.464%
Weight	6.08 mg
TFA	Pass
Sterility	Pass
Endotoxins (LPS)	Pass

These are the results provided for the identified batch. Customers should review the associated laboratory report to confirm the testing method, report details, and scope of each result. A test result should not be represented as independent certification unless the relevant documentation establishes that status.

Packaging and Product Form

CJC-1295 DAC 5mg is supplied as a lyophilized powder in a 7 mL vial identified as 6R. Lyophilization is a freeze-drying process used for various laboratory materials to remove water under controlled conditions.

The product is supplied in its dry, unreconstituted form. No claim is made here about a particular shelf life, storage temperature, or stability period because those details were not included in the supplied product specifications.

For accurate storage requirements, consult the manufacturer’s documentation and any applicable batch-specific instructions. Keep the container appropriately identified and follow the relevant laboratory’s procedures for handling and storage.

Frequently Asked Questions

What is CJC-1295 DAC 5mg?

It is a lyophilized peptide product labelled as 5 mg and supplied in a 7 mL vial. CJC-1295 DAC is a modified peptide studied in connection with growth hormone-releasing hormone signalling.

What form does the product come in?

The product is supplied as a dry, lyophilized powder. It has not been reconstituted.

What is the reported purity?

The supplied batch information reports a purity of 99.464%. Consult the associated laboratory report for the analytical method and interpretation of this result.

What does DAC mean?

DAC stands for Drug Affinity Complex. It describes a modification intended to extend the activity of certain peptides through interactions with circulating proteins.

Which quality tests are reported for this batch?

The supplied information lists purity, weight, TFA, sterility, and endotoxins (LPS). The recorded TFA, sterility, and endotoxin results are marked as passing.

Is the product intended for human use?

No. This product is presented for laboratory research purposes only. It is not intended for human or veterinary use, and the product information should not be used to guide self-administration or medical treatment.

Global Peptides Lab

Global Peptides Lab provides product specifications and available batch information to support clear product identification. When evaluating research materials, review the exact product designation, available laboratory documentation, and relevant quality-control information before determining whether a material meets your laboratory’s requirements.

CJC-1295 DAC 5mg is supplied as an unreconstituted, lyophilized research material. Buyers should rely on the applicable documentation for analytical details, storage requirements, and other technical information not specified on this page.

Research-use notice: This material is intended strictly for laboratory research and analytical purposes. It is not a medicine, dietary supplement, or product for human or veterinary consumption.